ATC code J07

ATC code J07 Vaccines is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup J07 is part of the anatomical group J Antiinfectives for systemic use.[4]

National versions of the ATC classification may include additional codes not present in this list, which follows the WHO version.

J07AC01 Anthrax antigen J07AD01 Brucella antigen J07AE01 Cholera, inactivated, whole cell J07AE02 Cholera, live attenuated J07AE51 Cholera, combinations with typhoid vaccine, inactivated, whole cell J07AF01 Diphtheria toxoid J07AG01 Hemophilus influenzae B, purified antigen conjugated J07AG51 Hemophilus influenzae B, combinations with toxoids J07AG52 Hemophilus influenzae B, combinations with pertussis and toxoids J07AG53 Hemophilus influenzae B, combinations with meningococcus C, conjugated J07AG54 Haemophilus influenza B, combinations with meningococcus C, Y, conjugated J07AH01 Meningococcus A, purified polysaccharides antigen J07AH02 Other meningococcal monovalent purified polysaccharides antigen J07AH03 Meningococcus A, C, bivalent purified polysaccharides antigen J07AH04 Meningococcus A, C, Y, W-135, tetravalent purified polysaccharides antigen J07AH05 Other meningococcal polyvalent purified polysaccharides antigen J07AH06 Meningococcus B, outer membrane vesicle vaccine J07AH07 Meningococcus C, purified polysaccharides antigen conjugated J07AH08 Meningococcus A, C, Y, W-135, tetravalent purified polysaccharides antigen conjugated J07AH09 Meningococcus B, multicomponent vaccine J07AH10 Meningococcus A, purified polysaccharides antigen conjugated J07AH11 Meningococcus A,B,C,Y,W-135, pentavalent purified polysaccharides antigen conjugated and factor H binding protein J07AJ01 Pertussis, inactivated, whole cell J07AJ02 Pertussis, purified antigen J07AJ51 Pertussis, inactivated, whole cell, combinations with toxoids J07AJ52 Pertussis, purified antigen, combinations with toxoids J07AK01 Plague, inactivated, whole cell J07AL01 Pneumococcus, purified polysaccharides antigen J07AL02 Pneumococcus, purified polysaccharides antigen conjugated J07AL52 Pneumococcus purified polysaccharides antigen and Haemophilus influenzae, conjugated J07AM01 Tetanus toxoid J07AM51 Tetanus toxoid, combinations with diphtheria toxoid J07AM52 Tetanus toxoid, combinations with tetanus immunoglobulin J07AN01 Tuberculosis, live attenuated J07AP01 Typhoid, oral, live attenuated J07AP02 Typhoid, inactivated, whole cell J07AP03 Typhoid, purified polysaccharide antigen J07AP10 Typhoid, combinations with paratyphi types J07AR01 Typhus exanthematicus, inactivated, whole cell J07AX01 Leptospira vaccines J07BA01 Encephalitis, tick-borne, inactivated, whole virus J07BA02 Encephalitis, Japanese, inactivated, whole virus J07BA03 Encephalitis, Japanese, live attenuated J07BB01 Influenza inactivated, whole virus J07BB02 Influenza, purified antigen J07BB03 Influenza, live attenuated J07BB04 Influenza, virus like particles J07BB05 Influenza, RNA-based vaccine J07BB55 Influenza and covid-19, RNA-based vaccine J07BC01 Hepatitis B, purified antigen J07BC02 Hepatitis A, inactivated, whole virus J07BC20 Combinations J07BD01 Measles, live attenuated J07BD51 Measles, combinations with mumps, live attenuated J07BD52 Measles, combinations with mumps and rubella, live attenuated J07BD53 Measles, combinations with rubella, live attenuated J07BD54 Measles, combinations with mumps, rubella and varicella, live attenuated J07BE01 Mumps, live attenuated J07BF01 Poliomyelitis oral, monovalent live attenuated J07BF02 Poliomyelitis oral, trivalent, live attenuated J07BF03 Poliomyelitis, trivalent, inactivated, whole virus J07BF04 Poliomyelitis oral, bivalent, live attenuated J07BG01 Rabies, inactivated, whole virus J07BH01 Rotavirus, live attenuated J07BH02 Rotavirus, pentavalent, live, reassorted J07BJ01 Rubella, live attenuated J07BJ51 Rubella, combinations with mumps, live attenuated J07BK01 Varicella, live attenuated J07BK02 Zoster, live attenuated J07BK03 Zoster, purified antigen J07BL01 Yellow fever, live attenuated J07BM01 Papillomavirus (human types 6, 11, 16, 18) J07BM02 Papillomavirus (human types 16, 18) J07BM03 Papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58) J07BN01 Covid-19, RNA-based vaccine J07BN02 Covid-19, viral vector, non-replicating J07BN03 Covid-19, inactivated virus J07BN04 Covid-19, protein subunit J07BN05 Covid-19, virus-like particles J07BP01 Chikungunya, live attenuated J07BP02 Chikungunya, virus-like particles J07BX01 smallpox and mpox vaccines J07BX02 Ebola vaccines J07BX04 Dengue virus vaccines J07BX05 Respiratory syncytial virus vaccines J07BX06 Enterovirus 71 vaccines J07CA01 Diphtheria-poliomyelitis-tetanus J07CA02 Diphtheria-pertussis-poliomyelitis-tetanus J07CA03 Diphtheria-rubella-tetanus J07CA04 Hemophilus influenzae B and poliomyelitis J07CA05 Diphtheria-hepatitis B-pertussis-tetanus J07CA06 Diphtheria-hemophilus influenzae B-pertussis-poliomyelitis-tetanus J07CA07 Diphtheria-hepatitis B-tetanus J07CA08 Hemophilus influenzae B and hepatitis B J07CA09 Diphtheria-hemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B J07CA10 Typhoid-hepatitis A J07CA11 Diphtheria-Hemophilus influenzae B-pertussis-tetanus-hepatitis B J07CA12 Diphtheria-pertussis-poliomyelitis-tetanus-hepatitis B J07CA13 Diphtheria-hemophilus influenzae B-pertussis-tetanus-hepatitis B-meningococcus A + C J07XA01 Malaria vaccines

• Vaccines for veterinary use are in the ATCvet group QI.